Evofem Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	-	-	-	2.77	7.73	48.89
Short-Term Investments	0.13	0.13	0.08	-	-	-
Cash & Short-Term Investments	0.13	0.13	0.08	2.77	7.73	48.89
Cash Growth	-37.13%	67.11%	-97.25%	-64.19%	-84.19%	105.39%
Accounts Receivable	4.44	9.83	5.74	1.13	6.45	1.07
Receivables	4.44	9.83	5.74	1.13	6.45	1.32
Inventory	1.68	1.58	1.7	5.38	7.67	7.16
Prepaid Expenses	0.65	0.39	0.78	1.39	2.6	16.7
Restricted Cash	0.84	0.74	0.58	1.21	5.06	22.56
Other Current Assets	0.18	0.94	0.34	0.83	0.63	1.1
Total Current Assets	7.92	13.61	9.21	12.7	30.14	97.73
Property, Plant & Equipment	0.62	0.55	1.31	8.35	11.17	11.19
Other Intangible Assets	5.24	9.6	-	-	-	-
Other Long-Term Assets	0.04	0.04	0.04	4.12	1.2	1.05
Total Assets	13.81	23.79	10.55	25.16	42.51	109.97
Accounts Payable	11.62	16.17	17.02	14.98	10.32	10.64
Accrued Expenses	4.97	9	6.84	6.3	13.72	10.99
Short-Term Debt	19.78	15.11	14.73	39.42	81.72	52.41
Current Portion of Long-Term Debt	32.17	30.77	28.54	26.27	27.21	-
Current Portion of Leases	0.12	0.08	0.1	2.31	2.33	2.29
Other Current Liabilities	9.52	9.31	5.24	4.55	2.37	0.95
Total Current Liabilities	78.19	80.45	72.46	93.83	137.66	77.28
Long-Term Debt	-	-	-	-	-	25.21
Long-Term Leases	0.07	0.01	0.01	3.13	4.42	6.03
Other Long-Term Liabilities	5.72	9.81	-	-	-	0.1
Total Liabilities	83.98	90.26	72.47	96.96	142.09	108.62
Common Stock	0.01	0.01	0	-	0.02	0.01
Additional Paid-In Capital	831.82	829.03	823.04	817.37	751.26	656.83
Retained Earnings	-900.18	-897.66	-888.7	-938.69	-860.68	-655.49
Comprehensive Income & Other	-6.72	-2.63	-0.85	49.53	5.09	-
Total Common Equity	-75.07	-71.26	-66.51	-71.8	-104.32	1.35
Shareholders' Equity	-70.17	-66.48	-61.92	-71.8	-99.58	1.35
Total Liabilities & Equity	13.81	23.79	10.55	25.16	42.51	109.97
Total Debt	52.15	45.97	43.37	71.13	115.68	85.94
Net Cash (Debt)	-52.02	-45.84	-43.3	-68.36	-107.95	-37.05
Net Cash Per Share	-0.46	-0.61	-0.04	-146.70	-1546.16	-1034.37
Filing Date Shares Outstanding	126.69	113.36	45.94	1.73	0.09	0.04
Total Common Shares Outstanding	123.96	113.36	20.01	0.98	0.09	0.04
Working Capital	-70.27	-66.84	-63.25	-81.13	-107.52	20.45
Book Value Per Share	-0.61	-0.63	-3.32	-72.91	-1203.63	31.05
Tangible Book Value	-80.3	-80.85	-66.51	-71.8	-104.32	1.35
Tangible Book Value Per Share	-0.65	-0.71	-3.32	-72.91	-1203.63	31.05
Machinery	0.13	0.73	1.23	2.17	2.15	1.7
Construction In Progress	0.4	0.43	1.16	1.57	2.41	2.25
Leasehold Improvements	-	-	-	3.39	3.39	1.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.